Kylee Maclachlan

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study

Amit Khot, Natalie Brajanovski, Donald P. Cameron et al. · Cancer Discovery · 2019 · 203 citations

Medicine, Oncology, Pharmacology +15

Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities

Bénedith Oben, Guy Froyen, Kylee Maclachlan et al. · Nature Communications · 2021 · 130 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Revealing the Impact of Structural Variants in Multiple Myeloma

Even H. Rustad, Venkata Yellapantula, Dominik Głodzik et al. · Blood Cancer Discovery · 2020 · 128 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Genomic Classification and Individualized Prognosis in Multiple Myeloma

Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu et al. · Journal of Clinical Oncology · 2024 · 119 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial

Benjamin Diamond, Neha Korde, Alexander M. Lesokhin et al. · The Lancet Haematology · 2021 · 95 citations

Medicine, Hematology, Oncology +15